India's National Pharmaceutical Pricing Authority (NPPA) has fixed the prices of 68 formulations, including treatments for diabetes, hypertension and HIV, as reported The Economic Times Friday.
The regulator noted that under the notification, which occurred under the 2013 drug price control order, the prices of 55 formulations were fixed, while those of 10 other formulations were revised.
Meanwhile, the NPPA additionally fixed the ceiling prices of three formulations.
Under the order, the NPPA can limit the price increases on fixed formulations to no more than 10 percent annually.
To read more NewsPoints articles, click here.